Cargando…

Clinical Characteristics of COVID-19 in Patients With Liver Injury

Detalles Bibliográficos
Autores principales:	Chen, Peng, Zhou, Benhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the AGA Institute 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213969/ https://www.ncbi.nlm.nih.gov/pubmed/32407783 http://dx.doi.org/10.1016/j.cgh.2020.04.043

Ejemplares similares

Clinical characteristics of COVID-19 patients with abnormal liver tests
por: Chen, Peng, et al.
Publicado: (2020)

Characteristics of pregnant patients with COVID-19 and liver injury
por: Deng, Guangtong, et al.
Publicado: (2020)

Reply to: “Clinical characteristics of COVID-19 patients with abnormal liver tests”
por: Cai, Qingxian, et al.
Publicado: (2020)

Pegylated G-CSF Combined with mFOLFIRINOX for Advanced Pancreatic Cancer Patients
por: Chen, Peng, et al.
Publicado: (2019)

Liver injury in remdesivir-treated COVID-19 patients
por: Zampino, Rosa, et al.
Publicado: (2020)

Liver Injury in COVID-19: Caution and Management
por: Cao, Jiasheng, et al.
Publicado: (2020)

Liver Injury in Liver Transplant Patients With COVID-19: A Histopathologic Analysis
por: NG, Alexander
Publicado: (2021)

Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests
por: Wu, Yanyan, et al.
Publicado: (2021)

Liver injury in COVID-19 – The culprit may not be COVID-19!
por: Singh, Aditya, et al.
Publicado: (2021)

Clinical characteristics and outcomes of COVID-19 patients with hypoxic hepatitis
por: Wu, Yanyan, et al.
Publicado: (2021)

Clinical characteristics of COVID-19 patients with complication of cardiac arrhythmia
por: Liu, Qin, et al.
Publicado: (2020)

Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis
por: Kunutsor, Setor K., et al.
Publicado: (2021)

Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes
por: Liu, Furong, et al.
Publicado: (2020)

COVID-19 Related Liver Injury: Call for International Consensus
por: Ye, Zheng, et al.
Publicado: (2020)

COVID-19-associated liver injury (COVALI): role of hepatologists
por: Sumida, Yoshio, et al.
Publicado: (2021)

Impact of Liver Injury in COVID-19 Patients: Single-center Retrospective Cohort Analysis
por: Desai, Jiten, et al.
Publicado: (2020)

Characteristics and clinical course of Covid-19 patients admitted with acute stroke
por: D’Anna, Lucio, et al.
Publicado: (2020)

Epidemiologic and clinical characteristics of patients with COVID-19 in hospitals in Sirjan at 2020
por: Khajoei, Rahimeh, et al.
Publicado: (2022)

Herbal Immune Booster–Induced Liver Injury in the COVID-19 Pandemic
por: Rastogi, Mukul, et al.
Publicado: (2022)

Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”
por: Li, Dongxiao, et al.
Publicado: (2021)

Clinical Characteristics, Diagnosis, and Outcomes of 6 Patients With COVID-19 Infection and Rhabdomyolysis
por: Buckholz, Adam P., et al.
Publicado: (2020)

The Topic of COVID-19–Related Liver Injury Needs More Rigorous Research
por: Lv, Xiu-He, et al.
Publicado: (2020)

Liver Injury in Severe COVID-19 Disease: Need a Closer Look!
por: Jindal, Ankur
Publicado: (2021)

The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease
por: Zhou, Bo, et al.
Publicado: (2020)

Clinical and laboratory characteristics of recovered versus deceased COVID-19 patients in Islamabad, Pakistan
por: Rana, Muhammad Suleman, et al.
Publicado: (2021)

Clinical characteristics and outcome of COVID-19 pneumonia in elderly subjects
por: Bongiovanni, Marco, et al.
Publicado: (2021)

Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor
por: Rismanbaf, Ali, et al.
Publicado: (2020)

Herbal Immunity Booster-Associated Liver Injury During COVID-19 Pandemic and Aflatoxins
por: Vamadevaiah, Ravishankar M., et al.
Publicado: (2022)

Liver transplantation in COVID-19 positive patients
por: Raveh, Yehuda, et al.
Publicado: (2021)

Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study
por: Ma, Jia, et al.
Publicado: (2020)

Clinical characteristics and risk factors for mortality among inpatients with COVID‐19 in Wuhan, China
por: Chen, Fuyang, et al.
Publicado: (2020)

Strategy for the control of drug-induced liver injury due to investigational treatments/drugs for COVID-19
por: Sato, Ken, et al.
Publicado: (2021)

Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany
por: Engelhardt, Monika, et al.
Publicado: (2020)

Clinical characteristics of SARS-CoV-2 fully-vaccinated patients dying with COVID-19 in Italy
por: Palmieri, Luigi, et al.
Publicado: (2022)

NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues
por: Mushtaq, Kamran, et al.
Publicado: (2021)

Characteristics of SARS-CoV-2 exhaled by COVID-19 patients
por: Lina, Liu, et al.
Publicado: (2023)

Remarks on “Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series”
por: Sharma, Rohit, et al.
Publicado: (2022)

Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France
por: Godaert, Lidvine, et al.
Publicado: (2020)

Letter: Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small-Cell Lung Cancer in China
por: Mu, Lifeng, et al.
Publicado: (2020)

Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues”
por: Ji, Dong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_afl1arc4bb0nh01jpjkkkoom4l